LC–MS Profiling of N-Glycans Derived from Human Serum Samples for Biomarker Discovery in Hepatocellular Carcinoma
暂无分享,去创建一个
Habtom W. Ressom | Chirag S. Desai | Mahlet G. Tadesse | Minkun Wang | Yehia Mechref | Tsung-Heng Tsai | Yue Luo | Rency S. Varghese | Yunli Hu | Shiyue Zhou | Cristina Di Poto | Y. Mechref | M. Tadesse | H. Ressom | K. Shetty | Minkun Wang | R. Varghese | Shiyue Zhou | Cristina Di Poto | Dina Hazem Ziada | Kirti Shetty | Yi Zhao | Yunli Hu | Tsung-Heng Tsai | Yue Luo | D. Ziada | C. Desai | Yi Zhao
[1] Mary Ann Comunale,et al. Increased Levels of Tetra-antennary N-Linked Glycan but Not Core Fucosylation Are Associated with Hepatocellular Carcinoma Tissue , 2012, Cancer Epidemiology, Biomarkers & Prevention.
[2] S. Nishimura,et al. Identification of novel serum biomarkers of hepatocellular carcinoma using glycomic analysis , 2013, Hepatology.
[3] Y. Mechref,et al. Microscale nonreductive release of O-linked glycans for subsequent analysis through MALDI mass spectrometry and capillary electrophoresis. , 2001, Analytical chemistry.
[4] Yehia Mechref,et al. High-throughput solid-phase permethylation of glycans prior to mass spectrometry. , 2008, Rapid communications in mass spectrometry : RCM.
[5] D. Woodfield. Hepatocellular carcinoma. , 1986, The New Zealand medical journal.
[6] Yehia Mechref,et al. Analysis of MALDI-TOF mass spectrometry data for detection of glycan biomarkers. , 2008, Pacific Symposium on Biocomputing. Pacific Symposium on Biocomputing.
[7] Ajit Varki,et al. alpha 2-6-Linked sialic acids on N-glycans modulate carcinoma differentiation in vivo. , 2008, Cancer research.
[8] C. Van Steenkiste,et al. Alteration of protein glycosylation in liver diseases. , 2009, Journal of hepatology.
[9] M. Bernardi,et al. Serum alpha-fetoprotein for diagnosis of hepatocellular carcinoma in patients with chronic liver disease: influence of HBsAg and anti-HCV status. , 2001, Journal of hepatology.
[10] M. Monsigny,et al. Increased alpha2,6 sialylation of N-glycans in a transgenic mouse model of hepatocellular carcinoma. , 1997, Cancer research.
[11] R. Contreras,et al. N‐glycomic changes in hepatocellular carcinoma patients with liver cirrhosis induced by hepatitis B virus , 2007, Hepatology.
[12] Joseph Zaia,et al. Mass spectrometry and the emerging field of glycomics. , 2008, Chemistry & biology.
[13] Yehia Mechref,et al. Identifying cancer biomarkers by mass spectrometry‐based glycomics , 2012, Electrophoresis.
[14] Navdeep Jaitly,et al. Decon2LS: An open-source software package for automated processing and visualization of high resolution mass spectrometry data , 2009, BMC Bioinformatics.
[15] R. Seruca,et al. The role of N-acetylglucosaminyltransferase III and V in the post-transcriptional modifications of E-cadherin. , 2009, Human molecular genetics.
[16] M. Monsigny,et al. Increased α2,6 Sialylation of N-Glycans in a Transgenic Mouse Model of Hepatocellular Carcinoma , 1997 .
[17] J. Esko,et al. The sweet and sour of cancer: glycans as novel therapeutic targets , 2005, Nature Reviews Cancer.
[18] Yehia Mechref,et al. Solid-phase permethylation for glycomic analysis. , 2009, Methods in molecular biology.
[19] L. R. Ruhaak,et al. Developments in the Identification of Glycan Biomarkers for the Detection of Cancer , 2013, Molecular & Cellular Proteomics.
[20] Yehia Mechref,et al. Solid-phase permethylation of glycans for mass spectrometric analysis. , 2005, Rapid communications in mass spectrometry : RCM.
[21] Scott R. Kronewitter,et al. Glycomics and disease markers. , 2009, Current opinion in chemical biology.
[22] Y. Mechref,et al. Identification of N-glycan serum markers associated with hepatocellular carcinoma from mass spectrometry data. , 2010, Journal of proteome research.
[23] Adrian M Di Bisceglie,et al. Diagnosis of hepatocellular carcinoma. , 2005, HPB : the official journal of the International Hepato Pancreato Biliary Association.
[24] Hyun Joo An,et al. Determination of glycosylation sites and site-specific heterogeneity in glycoproteins. , 2009, Current opinion in chemical biology.
[25] Xiaobo Song,et al. Modification of Sialylation Mediates the Invasive Properties and Chemosensitivity of Human Hepatocellular Carcinoma* , 2013, Molecular & Cellular Proteomics.
[26] Kiyoko F. Aoki-Kinoshita,et al. KEGG as a glycome informatics resource. , 2006, Glycobiology.
[27] Y. Mechref,et al. Comparative glycomic profiling of isotopically permethylated N-glycans by liquid chromatography/electrospray ionization mass spectrometry. , 2013, Rapid communications in mass spectrometry : RCM.
[28] H. Usuki,et al. Outer arm fucosylation of N-glycans increases in sera of hepatocellular carcinoma patients. , 2008, Biochemical and biophysical research communications.
[29] Samir Gupta,et al. Test Characteristics of -Fetoprotein for Detecting Hepatocellular Carcinoma in Patients with Hepatitis C , 2003, Annals of Internal Medicine.
[30] Y. Mechref,et al. Detection of Hepatocellular Carcinoma Using Glycomic Analysis , 2009, Clinical Cancer Research.
[31] Ruedi Aebersold,et al. High-throughput generation of selected reaction-monitoring assays for proteins and proteomes , 2010, Nature Methods.
[32] J. Gu,et al. Branched N‐glycans regulate the biological functions of integrins and cadherins , 2008, The FEBS journal.
[33] Pablo Tamayo,et al. Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[34] Y. Mechref,et al. Enhanced sensitivity of LC‐MS analysis of permethylated N‐glycans through online purification , 2011, Electrophoresis.
[35] C. Mathers,et al. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008 , 2010, International journal of cancer.
[36] H. M. Reis,et al. Pathogenic mechanisms in HBV- and HCV-associated hepatocellular carcinoma , 2013, Nature Reviews Cancer.
[37] Yehia Mechref,et al. Comparing MALDI‐MS, RP‐LC‐MALDI‐MS and RP‐LC‐ESI‐MS glycomic profiles of permethylated N‐glycans derived from model glycoproteins and human blood serum , 2012, Electrophoresis.
[38] Zhao-You Tang,et al. Elevated activity of N -acetylglucosaminyltransferase V in human hepatocellular carcinoma , 1998, Journal of Cancer Research and Clinical Oncology.
[39] Joris R Delanghe,et al. Diagnostic value of the hemopexin N-glycan profile in hepatocellular carcinoma patients. , 2010, Clinical chemistry.
[40] Y. Benjamini,et al. Controlling the false discovery rate: a practical and powerful approach to multiple testing , 1995 .
[41] Ullrich Köthe,et al. SIMA: Simultaneous Multiple Alignment of LC/MS Peak Lists , 2011, Bioinform..